Experiences of patients and family members with follow-up care, information needs and provider support after identification of Lynch Syndrome
-
Published:2023-12-19
Issue:1
Volume:21
Page:
-
ISSN:1897-4287
-
Container-title:Hereditary Cancer in Clinical Practice
-
language:en
-
Short-container-title:Hered Cancer Clin Pract
Author:
Mooney Ryan,Wu Yelena P.,Kehoe Kelsey,Volkmar Molly,Kohlmann Wendy,Koptiuch Cathryn,Kaphingst Kimberly A
Abstract
Abstract
Background
Lynch Syndrome is among the most common hereditary cancer syndromes and requires ongoing cancer surveillance, repeated screenings and potential risk-reducing surgeries. Despite the importance of continued surveillance, there is limited understanding of patient experiences after initial testing and counseling, the barriers or facilitators they experience adhering to recommendations, and how they want to receive information over time.
Methods
A cross-sectional, observational study was conducted among 127 probands and family members who had received genetic testing for Lynch Syndrome. We conducted semi-structured interviews to determine proband and family member experiences after receiving genetic testing results including their surveillance and screening practices, information needs, and interactions with health care providers. Both closed-ended and open-ended data were collected and analyzed.
Results
Both probands (96.9%) and family members (76.8%) received recommendations for follow-up screening and all probands (100%) and most family members (98.2%) who tested positive had completed at least one screening. Facilitators to screening included receiving screening procedure reminders and the ease of making screening and surveillance appointments. Insurance coverage to pay for screenings was a frequent concern especially for those under 50 years of age. Participants commented that their primary care providers were often not knowledgeable about Lynch Syndrome and surveillance recommendations; this presented a hardship in navigating ongoing surveillance and updated information. Participants preferred information from a knowledgeable health care provider or a trusted internet source over social media or support groups.
Conclusions
Probands and family members receiving genetic testing for Lynch Syndrome generally adhered to initial screening and surveillance recommendations. However, factors such as insurance coverage and difficulty finding a knowledgeable healthcare provider presented barriers to receiving recommended follow-up care. There is an opportunity to improve care through better transitions in care, procedures to keep primary care providers informed of surveillance guidelines, and practices so that patients receive reminders and facilitated appointment setting for ongoing screening and surveillance at the time they are due.
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Oncology
Reference12 articles.
1. Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA, Burt RW, Church JM, Dominitz JA, Johnson DA, Kaltenbach T, Levin TR. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on Colorectal cancer. Gastroenterology. 2014;147(2):502–26. 2. Kohlmann W, Gruber SB, Lynch S. 2004 Feb 5 [updated 2018 Apr 12]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle. 2019. 3. Win AK, Jenkins MA, Dowty JG, Antoniou AC, Lee A, Giles GG, Buchanan DD, Clendenning M, Rosty C, Ahnen DJ, Thibodeau SN. Prevalence and penetrance of major genes and polygenes for Colorectal cancer. Epidemiol Biomarkers Prev. 2017;26(3):404–12. 4. Schneider JL, Goddard KA, Muessig KR, Davis JV, Rope AF, Hunter JE, Peterson SK, Acheson LS, Syngal S, Wiesner GL, Reiss JA. Patient and provider perspectives on adherence to and care coordination of lynch syndrome surveillance recommendations: findings from qualitative interviews. Hereditary Cancer in Clinical Practice. 2018;16:1–0. 5. NCCN. Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2023. 2023.
|
|